What is neurocysticercosis and how is it acquired?
Neurocysticercosis (NCC) is infection of the central nervous system by cysticerci — the larval cysts of the pork tapeworm *Taenia solium*. Cysts can sit in the brain parenchyma, the subarachnoid space, the ventricles or the spinal cord, and that location decides both the clinical picture and the treatment.
T. solium is unusual because humans can be either host. A person who eats undercooked pork containing cysticerci becomes the definitive host and carries the adult tapeworm in the gut (taeniasis). A person who swallows T. solium eggs — through faecally contaminated food, water or fingers — becomes an intermediate host, and the larvae spread through the blood to muscle, skin, eye and brain (cysticercosis). StatPearls notes that T. solium is the exclusive cause of human cysticercosis.
What is the life cycle of Taenia solium?
- An adult T. solium lives in the human small intestine and sheds egg-filled proglottids in the stool. The adult develops over about 5–12 weeks and can persist for years, producing eggs continuously.
- Pigs eat the eggs from human faeces; larvae invade pig muscle and form cysticerci (the pig is the normal intermediate host).
- A human eats undercooked pork with viable cysts → the scolex attaches in the gut → taeniasis (human = definitive host).
- A human swallows eggs (faecal–oral, from a carrier or self) → oncospheres cross the gut wall, enter the circulation and lodge in tissues as cysticerci → cysticercosis (human = accidental intermediate host).
- Cysts in muscle and skin are usually silent; cysts in the brain (neurocysticercosis) and eye (ophthalmic cysticercosis) cause most of the disease.
| Feature | Taeniasis | Cysticercosis / neurocysticercosis |
|---|---|---|
| What is swallowed | Cysticerci in undercooked pork | Eggs (faecal–oral) |
| Human role | Definitive host (adult worm in gut) | Intermediate host (larval cysts in tissue) |
| Typical symptoms | Few or mild GI symptoms; passing segments | Seizures, headache, raised ICP, focal deficits |
| Treatment | Praziquantel single dose (WHO: 10 mg/kg) or niclosamide | Depends on cyst stage and location (see below) |
Why is neurocysticercosis a leading cause of acquired epilepsy?
WHO states that T. solium is the cause of 30% of epilepsy cases in many endemic areas, and up to 70% in some high-risk communities. The IDSA/ASTMH guideline similarly cites about 29% of seizures in endemic areas. Radiopaedia calls seizures the most common symptom and NCC the most common cause of seizures in young adults where the parasite is endemic. StatPearls lists India among the regions with the highest prevalence.
Seizures usually start months to years after infection. A living cyst modulates the host immune response and can sit quietly; seizures tend to appear when the host finally attacks the dying cyst and perilesional inflammation develops. As inflammation resolves, a calcified scar remains — and calcified lesions can themselves keep causing seizures.
- Parenchymal NCC — seizures (focal, focal with generalisation or generalised) and headache.
- Ventricular NCC — most often obstructive hydrocephalus.
- Subarachnoid NCC — communicating hydrocephalus, meningitis, stroke (vasculitis) or focal deficits.
- About 20% present with raised intracranial pressure, mainly obstructive hydrocephalus (IDSA).
- Rarer: spinal radiculopathy, cord compression, visual change, movement disorders, cognitive decline.
What are the four stages of a parenchymal cyst on imaging?
Parenchymal cysticerci evolve through four pathological stages described by Escobar. Each has a typical CT/MRI look, and the stage decides whether antiparasitic drugs help.
| Stage | What is happening | Imaging | Antiparasitic drugs? |
|---|---|---|---|
| 1. Vesicular | Viable parasite, intact membrane, no host reaction | Thin-walled CSF-like cyst; scolex may be seen as an eccentric dot; little or no oedema | Yes (viable cyst) |
| 2. Colloidal vesicular | Parasite dies; cyst fluid becomes turbid; inflammation begins | Ring-enhancing lesion with perilesional oedema | Yes, with steroids |
| 3. Granular nodular | Cyst retracts; oedema decreases | Smaller nodular or ring enhancement persists; less oedema | Yes (degenerating / single enhancing lesion) |
| 4. Nodular calcified | End-stage, quiescent remnant | Small dense calcification, no oedema; best seen on non-contrast CT | No — nothing alive to kill |
How is neurocysticercosis classified by location?
| Form | Imaging features | Key point |
|---|---|---|
| Calcified parenchymal | Nodular calcifications < 20 mm (often 1–5 mm), ± oedema or enhancement | No viable parasite |
| Single small enhancing lesion (SEL) | Single cystic or nodular enhancing lesion < 2 cm | A single parasite in the process of degeneration, with surrounding inflammation |
| Viable parenchymal | Vesicular lesions, scolex often visible on high-definition imaging | Intact cyst wall, fluid and scolex |
| Intraventricular | Cyst in a ventricle; obstructive or loculated hydrocephalus | Remove endoscopically if possible |
| Subarachnoid | Cysts in Sylvian fissure, basal cisterns or interhemispheric spaces; stroke or meningitis | Clustered, proliferating membranes (racemose), often no scolex |
| Spinal | Cysts in spinal subarachnoid space or cord | Individualised medical ± surgical treatment |
Two rare parenchymal forms are worth naming: cysticercal encephalitis — many inflamed cysts with diffuse cerebral oedema — and giant cysts larger than 20 mm. Most parenchymal cysts are 5–20 mm; a cystic lesion over 20 mm, with irregular borders or midline shift, is more likely to be something else.
How is neurocysticercosis diagnosed?
- Neuroimaging is essential. IDSA recommends both MRI and a non-contrast CT for every new patient: MRI for the scolex, oedema, small, posterior-fossa, ventricular and subarachnoid lesions; CT for calcifications.
- Serology: the test of choice is the enzyme-linked immunotransfer blot (EITB) on serum — serum is more sensitive than CSF. ELISAs with crude antigen should be avoided (sensitivity 41% vs 86% for EITB in one comparison).
- EITB is close to 100% sensitive with multiple, ventricular or subarachnoid cysts but poorly sensitive with a single lesion or calcifications only.
- Antigen detection (serum, CSF, urine) reflects the number of viable cysts and helps follow complex cases.
- Before treatment: fundoscopy, and screening for latent TB and *Strongyloides* in anyone likely to need prolonged steroids.
The revised Del Brutto diagnostic criteria (Del Brutto, Nash, White, Garcia and others, Journal of the Neurological Sciences, 2017) rest on two principles: neuroimaging is essential, and everything else is indirect evidence. They group findings into absolute, neuroimaging and clinical/exposure criteria.
| Category | Criteria |
|---|---|
| Absolute | Histological confirmation of the parasite; subretinal cysts; scolex within a cyst on imaging |
| Neuroimaging — major | Cystic lesions without scolex; enhancing lesions; multilobulated cysts; calcifications |
| Neuroimaging — confirmative | Resolution of cysts after cysticidal therapy; spontaneous resolution of a single enhancing lesion; migrating ventricular cysts on serial imaging |
| Neuroimaging — minor | Hydrocephalus; leptomeningeal enhancement |
| Clinical / exposure | Anticysticercal antibodies or antigens on a well-standardised test; systemic cysticercosis; household Taenia carrier; suggestive clinical picture; residence in an endemic area |
- Definitive diagnosis: one absolute criterion; or two major neuroimaging criteria + exposure; or one major + one confirmative + exposure; or one major + one minor + exposure after excluding confounding pathology.
- Probable diagnosis: one neuroimaging criterion + strong evidence of exposure.
How is neurocysticercosis treated according to IDSA/ASTMH?
Treatment has four strands — antiepileptic drugs, anti-inflammatory therapy, antiparasitic drugs and surgery — chosen by the form of disease. The IDSA/ASTMH guideline (dated 2017, published 2018) gives these recommendations:
| Form | Antiparasitic | Other measures |
|---|---|---|
| 1–2 viable parenchymal cysts | Albendazole 15 mg/kg/day in 2 doses with food (max 1200 mg/day) for 10–14 days | Corticosteroids started before antiparasitic drugs; AEDs if seizures |
| > 2 viable parenchymal cysts | Albendazole 15 mg/kg/day + praziquantel 50 mg/kg/day for 10–14 days | Steroids; AEDs; MRI every 6 months until cysts resolve |
| Single enhancing lesion | Albendazole for 1–2 weeks | Steroids before albendazole; AEDs if seizures |
| Calcified only | None | Symptomatic: AEDs; steroids not routine for perilesional oedema |
| Cysticercal encephalitis / untreated hydrocephalus | None — antiparasitics worsen oedema | Steroids for oedema; surgery (shunt) for hydrocephalus |
| Lateral / third ventricle cyst | Not before surgery | Neuroendoscopic removal |
| Subarachnoid (racemose) | Prolonged albendazole, or albendazole + praziquantel, until cysts resolve (can exceed a year) | High-dose steroids first; methotrexate as steroid-sparing agent; shunt for hydrocephalus |
| Intraocular cyst | Not recommended | Surgical removal |
- Steroid doses used: prednisone about 1 mg/kg/day or dexamethasone 0.1–0.4 mg/kg/day depending on the setting; tapered slowly.
- Monitoring: check blood counts and liver enzymes if albendazole runs beyond 14 days (hepatotoxicity, leukopenia).
- AEDs: give to every patient with seizures; no drug is proven better. For viable parenchymal disease, consider tapering after cyst resolution and 24 seizure-free months; for an SEL, after resolution and 6 seizure-free months if there are no risk factors (residual calcification, breakthrough seizures, > 2 seizures).
- Pregnancy: defer antiparasitic therapy until after delivery; manage raised ICP as usual.
- Children: same approach as adults, with weight-based doses.
Which neurocysticercosis facts are most often tested?
- Infective stage for cysticercosis: the egg (embryonated egg/oncosphere), not the cysticercus.
- Infective stage for taeniasis: the cysticercus in pork.
- Most common presentation: seizures. Most common cause of acquired epilepsy in endemic regions.
- Pathognomonic imaging: cyst with eccentric scolex ('hole with dot').
- Best test for calcification: non-contrast CT. Best for scolex and ventricular cysts: MRI.
- Serology of choice: serum EITB (immunoblot), not crude-antigen ELISA.
- Drug of choice: albendazole (plus praziquantel if > 2 viable cysts), always with corticosteroids.
- No antiparasitic for calcified cysts, cysticercal encephalitis or untreated hydrocephalus.
- Racemose cysts are subarachnoid, grape-like and often lack a scolex.
- Prevention: sanitation, hand hygiene, treating tapeworm carriers, meat inspection and cooking pork thoroughly; WHO's 'rapid impact' package also treats and vaccinates pigs.
Linked reading: anti-inflammatory dosing in corticosteroids, the egg-and-hand-hygiene logic in purification of water, and other high-yield infection topics on most repeated topics.